v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Operating activities:    
Net income (loss) $ 10,672 $ (11,823)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Stock-based compensation 65,976 48,686
Depreciation and amortization 13,310 14,805
Deferred income taxes 8,778 (10,420)
Net accretion of available-for-sale securities (3,001) (3,958)
Changes in operating assets and liabilities:    
Accounts receivable, net (8,144) 40,755
Inventory (5,255) 32,376
Prepaid expenses and other assets 11,297 7,659
Accounts payable (71) (11,809)
Accrued liabilities (5,936) (39,768)
Deferred revenue (3,702) (10,636)
Other long-term liabilities 4,983 (2,830)
Net cash provided by operating activities 88,907 53,037
Investing activities    
Purchases of property and equipment (13,670) (12,905)
Purchases of marketable securities (166,936) (228,456)
Sales of marketable securities 11,362 49,905
Maturities of marketable securities 168,350 115,529
Net cash used in investing activities (894) (75,927)
Financing activities:    
Proceeds from common stock issuances related to employee benefit plans 40,821 25,433
Repurchases of common stock (77,010) (3,738)
Net cash provided by (used in) financing activities (36,189) 21,695
Effect of exchange rate changes on cash and cash equivalents 26 147
Net increase (decrease) in cash and cash equivalents 51,850 (1,048)
Cash and cash equivalents at beginning of period 43,162 63,409
Cash and cash equivalents at end of period $ 95,012 $ 62,361

Source

10-Q XBRL Zip